< Back to previous page
Researcher
Pieter Gillard
- Disciplines:Endocrinology and metabolic diseases
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From1 Oct 2009 → Today
Projects
1 - 10 of 11
- Assessing novel technologies and glucometrics to improve glucose control and quality of life of people with type 1 diabetesFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Technological improvements in the management of type 1 diabetesFrom1 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The road to personalized management of type 1 diabetes with a focus on closed-loop devicesFrom2 Aug 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The use of novel technologies with a focus on the individual needs of people living with type 1 diabetesFrom1 Oct 2020 → 30 Sep 2021Funding: BOF - postdoctoral mandates
- Closed-loop insulin delivery in pregnant women with type 1 diabetes (the CRISTAL study)From1 Oct 2020 → TodayFunding: FWO Strategic Basic Research Grant, BOF - doctoral mandates
- Exploring the use of continuous glucose monitoring to improve glycemic control and quality of life in type 1 diabetesFrom1 Jan 2019 → 31 Mar 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Histology: a vital tool for endocrine and metabolic researchFrom1 Oct 2016 → 30 Sep 2018Funding: Fund Recuperation Fiscal Exemption
- Identification of patient-specific parameters for bolus calculators in type 1 diabetic patientsFrom15 Aug 2016 → 31 Dec 2020Funding: FWO Strategic Basic Research Grant
- Robust identification of patient-specific parameters for bolus calculators in type 1 diabetic patientsFrom1 Oct 2015 → 30 Sep 2017Funding: IOF - Industrial Research Fund
- The beta-cell and the immune system in type 1 diabetes: partners in crime - developing new therapies in type 1 diabetes through better understanding of beta-cell behaviour and use of novel immunomodulators.From1 Oct 2013 → 30 Sep 2018Funding: BOF - Concerted Research Project from 1994
Publications
81 - 90 of 114
- Hemoglobin A2-Leuven (α2δ2 143(H21) His>Asp): a novel delta-chain variant potentially interfering in hemoglobin A1c measurement using cation exchange HPLC(2016)
Authors: Davy Kieffer, Da Hae Lee, Pieter Gillard
Pages: E161 - E163 - Mortality in Individuals Treated with Glucose Lowering Agents: a Large, Controlled Cohort Study(2016)
Authors: Marc Claesen, Pieter Gillard, Frank De Smet, Bart De Moor, Chantal Mathieu
Pages: 461 - 9 - Serum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 Diabetes(2016)
Authors: Da Hae Lee, Pieter Gillard
- Plasma GAD65, a Marker for Early beta-Cell Loss After Intraportal Islet Cell Transplantation in Diabetic Patients(2015)
Authors: Pieter Gillard
Pages: 2314 - 2321 - Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients(2015)
Authors: Pieter Gillard
Pages: 551 - 560 - Diabetic nephropathy: Current therapeutic options(2015)
Authors: Pieter Gillard, Kathleen Claes
Pages: 622 - 631 - Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes(2015)
Authors: Pieter Gillard
Pages: 2753 - 2764 - Bariatric surgery induces weight loss but does not improve glycemic control in patients with type 1 diabetes(2014)
Authors: Matthias Lannoo, Steffen Fieuws, Chantal Mathieu, Pieter Gillard, Bart Van Der Schueren
Pages: E173 - E174 - Early Alteration of Kidney Function in Nonuremic Type 1 Diabetic Islet Transplant Recipients Under Tacrolimus-Mycophenolate Therapy(2014)
Authors: Pieter Gillard, Da Hae Lee, Dirk Kuypers, Chantal Mathieu
Pages: 451 - 7 - Minimal Functional β-Cell Mass in Intraportal Implants That Reduces Glycemic Variability in Type 1 Diabetic Recipients(2013)
Authors: Pieter Gillard, Da Hae Lee, Chantal Mathieu
Pages: 3483 - 8